Brief: Aceso Life Science Signed MOU With Scilex Holding

Aceso Life Science

24/03/2021 11:50

March 24 (Reuters) - Aceso Life Science Group Ltd  0474.HK :
    * SIGNED  MEMORANDUM OF UNDERSTANDING WITH SCILEX HOLDING
    * MOU FOR EXCLUSIVE LICENSE OF SCILEX SP-102
    * EXPECTED TOTAL VALUE OF EXCLUSIVE LICENSE FOR GREATER
CHINA
TERRITORY WILL BE IN RANGE OF USD60 MILLION TO USD80 MILLION
    * MOU ALSO FOR PRECLINICAL DATA TO SUPPORT LICENSE
APPLICATION FOR
SEMDEXA OR SP-102 IN MAINLAND CHINA FROM NMPA

Source text for Eikon:  ID:nHKS5msTXK 
Further company coverage:  0474.HK 

 ((Reuters.Briefs@thomsonreuters.com;))